These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

720 related articles for article (PubMed ID: 30612001)

  • 21. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease.
    Magalingam KB; Radhakrishnan A; Ping NS; Haleagrahara N
    Biomed Res Int; 2018; 2018():3740461. PubMed ID: 29707568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multi-faceted role of mitochondria in the pathology of Parkinson's disease.
    Trinh D; Israwi AR; Arathoon LR; Gleave JA; Nash JE
    J Neurochem; 2021 Mar; 156(6):715-752. PubMed ID: 33616931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View.
    Cenini G; Lloret A; Cascella R
    Oxid Med Cell Longev; 2019; 2019():2105607. PubMed ID: 31210837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
    Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
    BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.
    Area-Gomez E; Guardia-Laguarta C; Schon EA; Przedborski S
    J Clin Invest; 2019 Jan; 129(1):34-45. PubMed ID: 30601141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using C. elegans as a model for neurodegenerative diseases: Methodology and evaluation.
    Caldero-Escudero E; Romero-Sanz S; De la Fuente S
    Methods Cell Biol; 2024; 188():1-34. PubMed ID: 38880519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases.
    Moloudizargari M; Asghari MH; Ghobadi E; Fallah M; Rasouli S; Abdollahi M
    Ageing Res Rev; 2017 Nov; 40():64-74. PubMed ID: 28923312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are mitochondria critical in the pathogenesis of Alzheimer's disease?
    Reddy PH; Beal MF
    Brain Res Brain Res Rev; 2005 Nov; 49(3):618-32. PubMed ID: 16269322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration.
    Garabadu D; Agrawal N; Sharma A; Sharma S
    Behav Pharmacol; 2019 Dec; 30(8):642-652. PubMed ID: 31625975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial dysfunction in Parkinson's disease.
    Bose A; Beal MF
    J Neurochem; 2016 Oct; 139 Suppl 1():216-231. PubMed ID: 27546335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting autophagy in neurodegenerative diseases: From molecular mechanisms to clinical therapeutics.
    Ajoolabady A; Aslkhodapasandhokmabad H; Henninger N; Demillard LJ; Nikanfar M; Nourazarian A; Ren J
    Clin Exp Pharmacol Physiol; 2021 Jul; 48(7):943-953. PubMed ID: 33752254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative cleavage and polyadenylation of genes associated with protein turnover and mitochondrial function are deregulated in Parkinson's, Alzheimer's and ALS disease.
    Patel R; Brophy C; Hickling M; Neve J; Furger A
    BMC Med Genomics; 2019 May; 12(1):60. PubMed ID: 31072331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkin loss-of-function pathology: Premature neuronal senescence induced by high levels of reactive oxygen species?
    Buhlman LM
    Mech Ageing Dev; 2017 Jan; 161(Pt A):112-120. PubMed ID: 27374431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mtDNA mutations and common neurodegenerative disorders.
    Howell N; Elson JL; Chinnery PF; Turnbull DM
    Trends Genet; 2005 Nov; 21(11):583-6. PubMed ID: 16154228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae.
    Pimentel C; Batista-Nascimento L; Rodrigues-Pousada C; Menezes RA
    Oxid Med Cell Longev; 2012; 2012():132146. PubMed ID: 22701754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular insights into mechanisms of the cell death program: role in the progression of neurodegenerative disorders.
    Culmsee C; Landshamer S
    Curr Alzheimer Res; 2006 Sep; 3(4):269-83. PubMed ID: 17017859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.